Q BioMed Inc.
QBIODelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596062
Q BioMed Inc. was delisted in 2024; its insiders filed their last Form 4 on May 31, 2022; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Holders of 5% or more of QBIO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Q BioMed Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Q BioMed Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Q BioMed Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 4, 2024 | YA II PN, Ltd. | 13G/AOld format | – | – | – | SEC |
| Jan 3, 2023 | YA II PN, Ltd. | 13G/AOld format | – | – | – | SEC |
| Jun 1, 2022 | Jatwes Ari | 13G/AOld format | – | – | – | SEC |
| Jan 11, 2022 | YA II PN, Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 5, 2021 | YA II PN, Ltd. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Q BioMed Inc. shares.
No Form 144 notices for Q BioMed Inc. are on file.